<DOC>
	<DOCNO>NCT00006106</DOCNO>
	<brief_summary>RATIONALE : A specially modify virus call ONYX-015 may able kill tumor cell leave normal cell undamaged . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining ONYX-015 chemotherapy may kill tumor cell . PURPOSE : Phase I trial study effectiveness ONYX-015 combine cisplatin fluorouracil treat patient advanced head neck cancer .</brief_summary>
	<brief_title>ONYX-015 With Cisplatin Fluorouracil Treating Patients With Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility maximum tolerate dose ( MTD ) intraarterial ONYX-015 patient advance squamous cell cancer head neck . II . Determine feasibility tolerability intraarterial ONYX-015 MTD OR maximum theraputic dose , whichever low , combination intravenous cisplatin fluorouracil patient . III . Determine qualitative distribution ONYX-015 within limited tumor biopsy normal mucosal biopsy different dose level . IV . Determine response patient intraarterial ONYX-015 . V. Determine response patient cisplatin fluorouracil follow intraarterial ONYX-015 . PROTOCOL OUTLINE : This dose escalation study . Patients receive intraarterial infusion ONYX-015 . Treatment repeat 3-4 week absence disease progression unacceptable toxicity . Cohorts 3-8 patient receive escalate dos ONYX-015 maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 5 patient experience dose limit toxicity . Patients cohorts 1-4 follow 5 day infusion , weekly 3 week , week 6 , monthly thereafter 4 month . A fifth final cohort 10 patient receive ONYX-015 MTD . If MTD determine cohort 1-4 , patient receive high dose administer cohort 4 . Beginning 1-2 day ONYX-015 infusion , patient receive cisplatin IV 30-60 minute fluorouracil IV continuously 4 day . Treatment repeat 4 week absence disease progression unacceptable toxicity . Cisplatin fluorouracil IV treatment continue every 3-4 week discretion treat oncologist . Patients cohort 5 follow 5 day initial infusion , weekly 4 week , week 8 , monthly thereafter 4 month . PROJECTED ACCRUAL : A total 23-28 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<mesh_term>Mouth Neoplasms</mesh_term>
	<mesh_term>Lip Neoplasms</mesh_term>
	<mesh_term>ONYX015</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Histologically confirm squamous cell carcinoma head neck ( SCCHN ) incurable standard therapy Measurable evaluable disease Multiple SCCHN primary allow Metastases allow tumor treat confined head neck region Prior/Concurrent Therapy Biologic therapy : Recovered prior biologic therapy Chemotherapy : At least 3 week since prior chemotherapy recover Endocrine therapy : Recovered prior endocrine therapy Radiotherapy : At least 12 week since prior radiotherapy recover Surgery : Recovered prior surgery Other : Recovered prior diagnostic theraputic procedure Patient Characteristics Age : 18 physiologic 79 Performance status : ECOG 02 Life expectancy : Over 3 month Hematopoietic : WBC great 3,000/mm3 OR Absolute neutrophil count great 2,000/mm3 ; Platelet count great 100,000/mm3 ; Hemoglobin great 10 g/dL ( transfusion allow use solely meet eligibility criterion ) Hepatic : SGOT le 2.5 time upper limit normal ( ULN ) ; Alkaline phosphatase less 3 time ULN ; Bilirubin great 1.5 time ULN Renal : Creatinine le 1.6 mg/dL OR Creatinine clearance great 50 mL/min Cardiovascular : No active cardiovascular disease would limit physical activity ( i.e. , ability walk 50 foot without stop ) Pulmonary : No active pulmonary disease would limit physical activity ( i.e. , ability walk 50 foot without stop ) Other : No prior concurrent malignancy within past 3 year except limited basal cell squamous cell carcinoma skin carcinoma situ cervix ; Adequate nutritionally balance enteral intake least 1,800 kcal/day ( enteral feeding tube dependent allow ) ; No intravenous alimentation primary source calorie ; No serious illness medical condition would preclude study ( i.e. , active systemic lupus erythematosus , Crohn 's disease AIDS ) ; No prior immunodeficiency ( i.e. , HIV infection , organ transplant , chronic steroid use ) ; Not pregnant nursing ; Negative pregnancy test ; Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>adult solid tumor</keyword>
	<keyword>body system/site cancer</keyword>
	<keyword>cancer</keyword>
	<keyword>cellular diagnosis , hypopharyngeal cancer</keyword>
	<keyword>cellular diagnosis , laryngeal cancer</keyword>
	<keyword>cellular diagnosis , lip oral cavity cancer</keyword>
	<keyword>cellular diagnosis , nasopharyngeal cancer</keyword>
	<keyword>cellular diagnosis , oropharyngeal cancer</keyword>
	<keyword>cellular diagnosis , paranasal sinus nasal cavity cancer</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>hypopharyngeal cancer</keyword>
	<keyword>hypopharyngeal squamous cell carcinoma</keyword>
	<keyword>laryngeal cancer</keyword>
	<keyword>laryngeal squamous cell carcinoma</keyword>
	<keyword>lip oral cavity cancer</keyword>
	<keyword>lip oral cavity squamous cell carcinoma</keyword>
	<keyword>metastatic squamous neck cancer occult primary</keyword>
	<keyword>nasopharyngeal cancer</keyword>
	<keyword>nasopharyngeal squamous cell carcinoma</keyword>
	<keyword>oropharyngeal cancer</keyword>
	<keyword>oropharyngeal squamous cell carcinoma</keyword>
	<keyword>paranasal sinus nasal cavity cancer</keyword>
	<keyword>paranasal sinus nasal cavity squamous cell carcinoma</keyword>
	<keyword>recurrent hypopharyngeal cancer</keyword>
	<keyword>recurrent laryngeal cancer</keyword>
	<keyword>recurrent lip oral cavity cancer</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent nasopharyngeal cancer</keyword>
	<keyword>recurrent oropharyngeal cancer</keyword>
	<keyword>recurrent paranasal sinus nasal cavity cancer</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>solid tumor</keyword>
	<keyword>stage III hypopharyngeal cancer</keyword>
	<keyword>stage III laryngeal cancer</keyword>
	<keyword>stage III lip oral cavity cancer</keyword>
	<keyword>stage III nasopharyngeal cancer</keyword>
	<keyword>stage III oropharyngeal cancer</keyword>
	<keyword>stage III paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV hypopharyngeal cancer</keyword>
	<keyword>stage IV laryngeal cancer</keyword>
	<keyword>stage IV lip oral cavity cancer</keyword>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>stage IV oropharyngeal cancer</keyword>
	<keyword>stage IV paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage , hypopharyngeal cancer</keyword>
	<keyword>stage , laryngeal cancer</keyword>
	<keyword>stage , lip oral cavity cancer</keyword>
	<keyword>stage , metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage , nasopharyngeal cancer</keyword>
	<keyword>stage , oropharyngeal cancer</keyword>
	<keyword>stage , paranasal sinus nasal cavity cancer</keyword>
</DOC>